CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
CMPI
Delisted
CMPI was delisted on the 27th of May, 2022.
34 hedge funds and large institutions have $97.3M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.28M | |
| 2 | +$410K | |
| 3 | +$241K | |
| 4 |
E
Ergoteles
New York
|
+$158K |
| 5 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$149K |
Top Sellers
| 1 | -$2.07M | |
| 2 | -$1.01M | |
| 3 | -$987K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$376K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$298K |